CVS Health Corporation (NYSE: CVS) is -18.63% lower on its value in year-to-date trading and has touched a low of $74.52 and a high of $109.69 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CVS stock was last observed hovering at around $75.40 in the last trading session, with the day’s gains setting it 0.43% off its average median price target of $110.50 for the next 12 months. It is also 46.97% off the consensus price target high of $143.00 offered by 23 analysts, but current levels are 20.18% higher than the price target low of $95.00 for the same period.
Currently trading at $75.83, the stock is -8.14% and -12.00% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.64 million and changing 0.57% at the moment leaves the stock -19.64% off its SMA200. CVS registered -29.12% loss for a year compared to 6-month loss of -24.96%.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
The stock witnessed a -14.34% gain in the last 1 month and extending the period to 3 months gives it a -25.06%, and is -1.52% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.02% over the week and 1.78% over the month.
CVS Health Corporation (CVS) has around 300000 employees, a market worth around $97.25B and $322.47B in sales. Current P/E ratio is 24.30 and Fwd P/E is 8.38. Profit margin for the company is 1.30%. Distance from 52-week low is 1.76% and -30.87% from its 52-week high. The company has generated returns on investments over the last 12 months (5.10%).
CVS Health Corporation (CVS) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for CVS Health Corporation (CVS) is a “Overweight”. 23 analysts offering their recommendations for the stock have an average rating of 2.10, where 6 rate it as a Hold and 4 think it is a “Overweight”. 13 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
CVS Health Corporation is expected to release its quarterly report on 05/03/2023.The EPS is expected to shrink by -47.30% this year
CVS Health Corporation (CVS) Top Institutional Holders
The shares outstanding are 1.31B, and float is at 1.28B with Short Float at 1.15%.
CVS Health Corporation (CVS) Insider Activity
A total of 15 insider transactions have happened at CVS Health Corporation (CVS) in the last six months, with sales accounting for 5 and purchases happening 10 times. The most recent transaction is an insider sale by Moriarty Thomas M, the company’s EVP & General Counsel. SEC filings show that Moriarty Thomas M sold 137,466 shares of the company’s common stock on Dec 15 at a price of $98.36 per share for a total of $13.52 million. Following the sale, the insider now owns 0.61 million shares.
CVS Health Corporation disclosed in a document filed with the SEC on Aug 04 that Lotvin Alan (EVP&President-PharmacyServices) sold a total of 22,541 shares of the company’s common stock. The trade occurred on Aug 04 and was made at $104.00 per share for $2.34 million. Following the transaction, the insider now directly holds 0.11 million shares of the CVS stock.
Still, SEC filings show that on Aug 03, Lotvin Alan (EVP&President-PharmacyServices) disposed off 120,899 shares at an average price of $98.00 for $11.85 million. The insider now directly holds 109,183 shares of CVS Health Corporation (CVS).
CVS Health Corporation (CVS): Who are the competitors?
The company’s main competitors (and peers) include Amazon.com Inc. (AMZN) that is trading -32.11% down over the past 12 months and UnitedHealth Group Incorporated (UNH) that is -5.20% lower over the same period. Elevance Health Inc. (ELV) is 0.17% up on the 1-year trading charts.